Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Lumibird SA is a France-based company specializing in the design, manufacture, and marketing of high-performance lasers for scientific, industrial, and medical applications. With over 50 years of expertise in key technologies including solid-state lasers, laser diodes, and fiber lasers, it produces a diverse portfolio such as compact pulsed Nd lasers, tunable systems, fiber amplifiers, high-power fiber lasers, diode-pumped solid-state lasers, semiconductor modules, and eye-safe lasers at 1.5 µm. These products serve research laboratories, universities, manufacturing processes, defense and space sectors, LiDAR for environment and topography, ophthalmology, dermatology, and aesthetics. Operating through subsidiaries like Quantel Medical for ocular diagnostics and surgical lasers, Quantel USA for fiber and tunable lasers, and Quantel Derma AT for dermatology solutions, Lumibird maintains a global presence with facilities in France and the USA, employing around 1,000 people. Headquartered in Lannion, France since its incorporation in 1970, and formerly known as Quantel SA, Lumibird plays a pivotal role in advancing photonics innovations across multiple industries.
11.22% operating margin is respectable but not wide. ROIC at 5.33%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue grew 8.8%, steady but not accelerating.
Net debt of €85M represents 6.7x FCF, leverage limits flexibility.
Profitability & Returns
Revenue (TTM)
€229M
▲ +8.8% YoY
Net Income (TTM)
€14M
▲ +146.0% YoY
Op. Margin
11.22%
▲ +4.1pp YoY
ROIC
5.33%
▲ +1.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€13M
▲ +10.9% YoY
Op. Cash Flow (TTM)
€20M
▲ +69.4% YoY
Net Debt
€85M
Cash & Equiv.
€62M
3Y CAGR: +5.6%
Continue Research